Date Name Title Filing Type Shares Traded Price Total Held
Apr 13, 2007
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 90,444 -- --
Apr 13, 2007
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 90,444 $10.56 157,540
Dec 16, 2016
Director, President and CSO
Director, President and CSO Form 4 Bona fide gift 89,427 -- 500,000
Dec 16, 2016
Director, President and CSO
Director, President and CSO Form 4 Bona fide gift 89,427 -- 159,324
Dec 14, 2017
Director, President and CSO
Director, President and CSO Form 4 Bona fide gift 89,264 -- 500,847
Dec 14, 2017
Director, President and CSO
Director, President and CSO Form 4 Bona fide gift 89,264 -- 244,670
Jan 05, 2005
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 87,666 -- 87,666
Sep 17, 2003
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 87,060 -- --
Sep 17, 2003
Director, EVP, CSO, & Pres Regn Res Labs
Director, EVP, CSO, & Pres Regn Res Labs Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 87,060 $4.25 172,948
Dec 30, 2020
Director, President and Chief Scientific
Director, President and Chief Scientific Form 4 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 86,096 $483.25 822,207

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.